Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
South Korea · Delayed Price · Currency is KRW 3,230.00
-60.00 (-1.82%)
At close: Apr 30, 2026
Vivozon Pharmaceutical Market Cap
Vivozon Pharmaceutical has a market cap or net worth of 194.33 billion as of April 30, 2026. Its market cap has decreased by -37.23% in one year.
Market Cap
194.33B
Enterprise Value
231.51B
Revenue
59.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,230.00
Market Cap Chart
Since November 18, 2005, Vivozon Pharmaceutical's market cap has increased from 72.45B to 194.33B, an increase of 168.23%. That is a compound annual growth rate of 4.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 194.33B | -3.16% |
| Dec 30, 2025 | 200.68B | -40.93% |
| Dec 30, 2024 | 339.73B | 134.89% |
| Dec 28, 2023 | 144.64B | -2.99% |
| Dec 29, 2022 | 149.09B | -19.87% |
| Dec 30, 2021 | 186.05B | -37.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DAE HWA Pharmaceutical | 262.92B |
| NOVAREX | 258.45B |
| GREEN CROSS WellBeing | 239.03B |
| High Tech Pharm | 205.33B |
| OPTUS Pharmaceutical | 165.70B |
| Kyung Dong Pharmaceutical | 150.87B |
| Organoidsciences | 149.50B |
| PHARMARESEARCH BIO | 144.65B |